Sign inJoin waitlistJoin the waitlist

Kaleb Yohay

Director, Neurofibromatosis Program · NYU Grossman School of Medicine

Credentials: · · ·

History

Division of Child Neurology and Comprehensive Neurofibromatosis Center · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Neurodevelopmental Disabilities
2002–2006
Child Neurology
Johns Hopkins University School of Medicine
1999–2002
Pediatrics
Johns Hopkins Hospital
1997–1999
Robert Larner College of Medicine
1993–1997

Research

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Genetics in Medicine · 2021 · 627 citations
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Genetics in Medicine · 2022 · 234 citations
Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine · 2018 · Last of 5 authors · 143 citations

Jaishri Blakeley
10 papers
Scott Plotkin
10 papers
Nicole Ullrich
8 papers
Barry Kosofsky
7 papers
Bruce Korf
7 papers
David Stevenson
6 papers
Ronald Crystal
6 papers
Brigitte Widemann
5 papers
Devorah Segal
5 papers
DB
Dusica Babovic-Vuksanovic
5 papers
Justin Jordan
5 papers
Michael Fisher
5 papers

Clinical trials

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
Principal investigator · Completed
NYU Langone Health
2018–2019
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Site PI · Recruiting · Phase 2
Healx Limited
2025–2028
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Site PI · Recruiting · Phase 2
Scott R. Plotkin, MD, PhD
2020–2030